Last reviewed · How we verify
NCT04555642
Early Diagnosis of Therapy-associated Cardiotoxicity Basing on Multi-tracer Multimodality PET/MRI
trial in Positron-Emission Tomography in 120 participants. Status unknown.
28 December 2021
Quick facts
| Lead sponsor | Peking University Cancer Hospital & Institute |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 15 September 2020 |
| Primary completion | 28 December 2021 |
| Estimated completion | 28 February 2022 |
| Sites | 1 location across China |
Conditions studied
- Positron-Emission Tomography — all drugs for Positron-Emission Tomography →
- Magnetic Resonance Imaging — all drugs for Magnetic Resonance Imaging →
Sponsor
Peking University Cancer Hospital & Institute
Who can join
Adults 18 to 75, any sex, with Positron-Emission Tomography or Magnetic Resonance Imaging. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Using Multi-tracer to early diagnosis of therapy-associated cardiotoxicity using multimodality PET/MRI.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Cancer Therapy-Induced Cardiotoxicity-A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy.
Choksey A, Timm KN. · · 2021 · cited 29× · PMID 35008867 · DOI 10.3390/ijms23010441 -
From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
Zhang Z, Tao J, Qiu J, Cao Z, et al · · 2024 · cited 21× · PMID 37726505 · DOI 10.1007/s13402-023-00872-z -
Cardiovascular Magnetic Resonance Imaging in the Early Detection of Cardiotoxicity Induced by Cancer Therapies.
Wei X, Lin L, Zhang G, Zhou X. · · 2022 · cited 4× · PMID 36010197 · DOI 10.3390/diagnostics12081846
Verify or expand the search:
- PubMed search for NCT04555642
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Positron-Emission Tomography
Currently open trials in the same condition.
- NCT06387381 — 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease · EARLY_PHASE1 · recruiting
- NCT06203574 — Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors · NA · recruiting
- NCT05873777 — 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG · NA · recruiting
- NCT05610098 — Gene Expression Profiles in Spinal Tuberculosis. · recruiting
- NCT04416165 — Comparison of FDG and FAPI in Patients With Various Types of Cancer · NA · recruiting
Other Peking University Cancer Hospital & Institute trials
Trials by the same sponsor.
- NCT07527806 — Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Im · Phase 2 · not yet recruiting
- NCT07529002 — Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors · recruiting
- NCT07417241 — SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized Study · Phase 2 · not yet recruiting
- NCT07470203 — Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer · not yet recruiting
- NCT07394192 — Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-I · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04555642 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University Cancer Hospital & Institute
- Last refreshed: 26 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04555642.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing